Thrombosis and Haemostasis, Table of Contents Thromb Haemost 1967; 18(03/04): 393-403DOI: 10.1055/s-0038-1655048 Originalarbeiten — Original Articles — Travaux Originaux Schattauer GmbH Die Bestimmung des Proaktivators des fibrinolytischen Systems mit einer quantitativen kaseinolytischen Methode Authors Author Affiliations F Spöttl 1 Aus der Medizinischen Universitätsklinik Innsbruck (Vorstand: Prof. Dr. H. Braunsteiner) Recommend Article Abstract Buy Article(opens in new window) Zusammenfassung Es wird eine quantitative kaseinoly tische Methode zur Bestimmung des Proaktivators im menschlichen Plasma angegeben. Als Substrat für den durch Streptokinasezusatz gebildeten Aktivator wird ein plasminogenhaltiges Rindereuglobulinpräparat verwendet, das gebildete Plasmin wird in einem kaseinolytischen System gemessen. Die Phase der Aktivatorbildung und Plasminogenaktivierung sowie die Antiplasmininterferenz werden untersucht. Schließlich werden JSTormwerte angegeben. Full Text References Literatur Ablondi F. B, Hagan J. J, Philips M, De JRenzo E. C. Inhibition of plasmin, trypsin and the streptokinase-activated fibrinolytic system by e-aminocaproic acid. Arch. Biochem. 82: 153 1959; Alkjaersig N, Fletcher A. P, Sherry S. The mechanism of clot dissolution by plasmin. J. clin. Invest. 38: 1086 1959; Astrup T, Müllertz S. The fibrin plate method for estimating fibrinolytic activity Arch. Biochem. 40: 346 1952; Astrup T, Sterndorff J. A fibrinolytic system in human milk. Proc. Soc. exp. Biol. (N. Y.) 84: 605 1953; Blix S. The proactivator of the fibrinolytic system in human plasma. Acta med. scand. 171: 83 1962; Blombach B, Blombäck M, Senning A, Wallen P. Fibrinolys och Fibrinogenolys som Orsak till Komplikationer inom Kirurgi och Obstetrik. Nord. Med. 53: 1019 1955; Christensen L. R, MacLeod C. M. A proteolytic enzyme of serum: Charakterisation, activation and reaction with inhibitors. J. gen. Physiol. 28: 559 1945; Christensen L. R. Methods for measuring the activity of components of the streptococcal fibrinolytic system. J. clin. Invest. 28: 163 1949; Derechin M. The assay of human plasminogen with casein as substrate. Biochem. J. 78: 443 1961; De Vreker R. A. A technique for routine evaluation of plasminogen in human during streptokinase therapy. Actahaemat. (Basel.) 34: 305 1965; Heimburger N. Neuere Erkenntnisse über den Mechanismus der Fibrinolyse unter besonderer Berücksichtigung der Fibrinagar-Elektrophorese. Behringwerk-Mitteilungen. 41: 84 1962; Hedner U, Nilsons I. M. Determination of plasminogen in human plasma by a casein method. Thrombos. Diathes. haemorrh. (Stuttg.) 14: 545 1965; Kline D. L, Fishman J. B. Proactivator function of human plasmin as shown by lysine esterase assay. J. biol. Chem. 236: 2807 1961; Kline D. L. Interaction of streptokinase and plasminogen to form an SK-plasmin activator of plasminogen. 9th. Congr. Soc. Europ. haematol. Lissabon; 1963 Kline D. L. Plasminogen and proactivator concentration in human plasma. Proc. Soc. exp. Biol. (N. Y.) 121: 184 1966; Lassen M. The estimation of fibrinolytic components by means of the lysis time method. Scand. J. clin. Lab. Invest. 10: 384 1958; Lassen M. The reaction between streptokinase and human plasma. Acta chem. scand. 13: 1332 1959; Maki M, Beller E. K. Comparative studies of fibrinolytic inhibitors in vitro. Thrombos. Diathes. haemorrh. (Stuttg.) 16: 668 1966; Mitchell P, Cope I. The estimation of plasminogen in human serum or plasma. Clin. chim. Acta. 11: 414 1965; Müllertz S. Chemistry of fibrinolysis, discussion: Theories of plasminogen activation. Thrombos. Diathes. haemorrh. (Suppl. 01) ad Vol. VI 1960; 142. Müllertz S. Components interacting in the formation activator in human blood. I. Internat. Tagung über Thrombose und Embolie, Basel 1954. Schwabe; Basel: 1955 Müllertz S. Formation and properties of the activator of plasminogen and of human and bovine plasmin. Biochem. J. 61: 424 1955; Nilsson I. M, Skanse B, Gydell K. Fibrinolysis in Boeck’s sarcoid. Acta med. scand. 159: 463 1957; Norman P. h. S. Effect of urea and methylamine on plasmin. Proc. Soc. exp. Biol. (N. Y.) 96: 709 1957; Norman P. h. S. Studies of the plasmin system. II. Inhibition of plasmin by serum or plasma. J. exp. Med. 108: 53 1958; Norman P. h. S, Hill B. M. Studies of the plasmin system. III. Physical properties of the two plasmin inhibitors in plasma. J. exp. Med. 108: 639 1958; Remmert L. F, Cohen P. h. P. Partial purification and properties of a proteolytic enzyme of human serum. J. biol. Chem. 181: 431 1949; Richard M. N, Sanders B. E. Effect of lysine and wetting agents on activated plasminogen solutions. Canad. J. Biochem. 41: 211 1963; Rimon S, Stupp Y, Rimon A. Preparation of an insoluble derivate of plasminogen activator and the conversion of proactivator to activator. Proc. 10th. Congr. int. Soc. haematol. Stockholm; 1964 Rimon S, Stupp Y, Rimon A. Studies on the activation of plasminogen. III. Insoluble derivates of the proactivator and the activator.. Canad. J. Biochem. 44: 415 1966; Shamash Y, Rimon A. The plasmin inhibitors of plasma. I. A method for their estimation. Thrombos. Diathes. haemorrh. (Stuttg.) 12: 119 1964; Spöttl F, Gonstantini R, Holzknecht F. Der Proaktivatorgehalt im fibrinolytischen System von Hyperlipämikern. Actahaemat. (Basel.) 38: 377 1967;
